Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study.
Galluzzo M, Talamonti M, Atzori L, Bardazzi F, Campanati A, Di Cesare A, Diotallevi F, Flori ML, Mugheddu C, Offidani A, Piaserico S, Russo F, Sacchelli L, Bianchi L, Prignano F. Galluzzo M, et al. Among authors: mugheddu c. Expert Opin Biol Ther. 2022 Apr;22(4):547-554. doi: 10.1080/14712598.2022.2029841. Epub 2022 Jan 20. Expert Opin Biol Ther. 2022. PMID: 35043741 Free article.
Elderly psoriatic patients under biological therapies: an Italian experience.
Ricceri F, Bardazzi F, Chiricozzi A, Dapavo P, Ferrara F, Mugheddu C, Romanelli M, Rongioletti F, Prignano F. Ricceri F, et al. Among authors: mugheddu c. J Eur Acad Dermatol Venereol. 2019 Jan;33(1):143-146. doi: 10.1111/jdv.15139. Epub 2018 Jul 6. J Eur Acad Dermatol Venereol. 2019. PMID: 29906311
Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice.
Esposito M, Prignano F, Rongioletti F, Hansel K, Bianchi L, Pescitelli L, Lazzeri L, Ricceri F, Mugheddu C, Bavetta M, Zangrilli A, Bianchi L, Bini V, Stingeni L. Esposito M, et al. Among authors: mugheddu c. J Dermatolog Treat. 2019 Aug;30(5):441-445. doi: 10.1080/09546634.2018.1529382. Epub 2018 Nov 6. J Dermatolog Treat. 2019. PMID: 30273075 Free article.
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience.
Conti A, Peccerillo F, Amerio P, Balato A, Bardazzi F, Bianchi L, Burlando M, Cannavò SP, Chiricozzi A, Dapavo P, De Simone C, Fargnoli MC, Gambardella A, Gisondi P, Malagoli P, Malara G, Mugheddu C, Offidani AM, Piaserico S, Prignano F, Stingeni L, Pellacani G. Conti A, et al. Among authors: mugheddu c. Br J Dermatol. 2019 Jun;180(6):1547-1548. doi: 10.1111/bjd.17580. Epub 2019 Feb 21. Br J Dermatol. 2019. PMID: 30578668 No abstract available.
40 results